Methods of increasing endogenous erythropoietin (EPO)

Details for Australian Patent Application No. 2009200018 (hide)

Owner FibroGen, Inc.

Inventors Flippin, Lee A.; Lin, Al Y.; Neff, Thomas B.; Klaus, Stephen J.; Guenzler-Pukall, Volkmar; Melekhov, Alex; Arend, Michael P.; Wang, Qingjian

Agent FB Rice

Pub. Number AU-B-2009200018

Parent 2002357096

Filing date 2 January 2009

Wipo publication date 5 February 2009

Acceptance publication date 24 May 2012

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

A61K 31/00 (2006.01)

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4418 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine

A61K 31/47 (2006.01) - Quinolines

A61K 31/472 (2006.01) - Non-condensed isoquinolines, e.g. papaverine

A61K 31/4745 (2006.01)

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/555 (2006.01) - containing heavy metals, e.g. hemin, hematin, melarsoprol

A61K 31/63 (2006.01) - Compounds containing para-N-benzene- sulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonohydrazide

A61K 33/26 (2006.01) Medicinal preparations containing inorganic active ingredients - Iron

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 7/06 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/08 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

29 January 2009 Complete Application Filed

5 February 2009 Application Open to Public Inspection

  Published as AU-B-2009200018

24 May 2012 Application Accepted

  Published as AU-B-2009200018

20 September 2012 Standard Patent Sealed

11 October 2012 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 25 Sep 2012 . Address for service in Australia - FB Rice Level 23 44 Market Street Sydney NSW 2000

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009200019-Mesenchymal stem cells and uses therefor

2009200017-Anti-CD40 monoclonal anitbody